> top > docs > PMC:7029759 > spans > 26248-26407 > annotations

PMC:7029759 / 26248-26407 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
622 64-68 Gene denotes ACE2 Gene:59272
630 58-63 Species denotes human Tax:9606
631 150-158 Species denotes patients Tax:9606
636 70-76 Chemical denotes rhACE2
650 127-131 Disease denotes ARDS MESH:D012128
651 135-149 Disease denotes critically ill MESH:D016638

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T555 58-63 SP_6;NCBITaxon:9606;PG_10 denotes human
T554 64-68 PG_10;PR:000003622 denotes ACE2

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T97 127-131 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T239 58-63 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T168 0-159 Sentence denotes Based on these promising preclinical studies, recombinant human ACE2 (rhACE2) was moved into clinical trials in order to treat ARDS in critically ill patients.